Owkin, AstraZeneca Expand AI Partnership for Drug Development
Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence…
Trending
- Owkin, AstraZeneca Expand AI Partnership for Drug Development
- VOLGA Trial Shows Promise in Muscle-Invasive Bladder Cancer
- Arna Pharma, Slate Run Launch U.S. Specialty Pharma Venture
- Bristol Myers, Hengrui Forge $15 Billion Drug Development Alliance
- EU Approves Pfizer’s HYMPAVZI for Hemophilia Patients With Inhibitors
- Kura Reports Strong AML Trial Results for Ziftomenib
- Zydus to Acquire Assertio in $166 Million Deal
- FDA Grants Fast Track Status to Zai Lab Cancer Therapy
- Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery
- CALYPSO Trial Highlights Benefits of Eneboparatide in Hypoparathyroidism
Top Headlines
VOLGA Trial Shows Promise in Muscle-Invasive Bladder Cancer
AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative…
Arna Pharma, Slate Run Launch U.S. Specialty Pharma Venture
Arna Pharma Inc. and Slate Run Pharmaceuticals have officially finalized a joint venture aimed at creating a larger…
Bristol Myers, Hengrui Forge $15 Billion Drug Development Alliance
Bristol Myers Squibb and Hengrui Pharma have entered into a broad strategic collaboration and licensing agreement…
EU Approves Pfizer’s HYMPAVZI for Hemophilia Patients With Inhibitors
Pfizer Inc. announced that the European Commission has approved an expanded indication for HYMPAVZI, allowing its…
Kura Reports Strong AML Trial Results for Ziftomenib
Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced updated clinical data from the frontline arm of the Phase 1…
Featured Event
Clinical Trials
VOLGA Trial Shows Promise in Muscle-Invasive Bladder Cancer
AstraZeneca announced positive interim results from the Phase III VOLGA clinical trial, showing that perioperative treatment with Imfinzi combined…
Madrigal Licenses Gene Therapy Candidate for MASH Treatment
Madrigal Pharmaceuticals, Inc. has entered into an exclusive global licensing agreement with Arrowhead Pharmaceuticals to develop and commercialize…
Akeso Advances First Trispecific Antibody Into Clinical Trials
Akeso, Inc. has announced that its novel trispecific antibody candidate, AK150, has received Investigational New Drug (IND) clearance from the…
Vima Therapeutics Advances Dystonia Drug Into Phase 2 Trials
Vima Therapeutics has announced significant progress in the development of its experimental treatment for movement disorders, revealing that the first…
Akeso and INOVIO Partner on Novel Glioblastoma Combination Trial
Biotechnology companies Akeso, Inc. and INOVIO have announced a clinical trial collaboration and supply agreement to evaluate a new combination…
Novartis Remibrutinib Shows Phase III Success in CIndU
Novartis has announced positive topline results from its pivotal Phase III RemIND trial evaluating oral remibrutinib in patients with chronic…
Fast shipping, security and absolute privacy is our main goal Viagra-Buy.com/ savings on their medication from a licensed and certified pharmacy.
The best pharmacy in america Viagra-Buy.com Fast delivery, best prices and for real men
Owkin, AstraZeneca Expand AI Partnership for Drug Development
Owkin has entered into a new multi-year agreement with AstraZeneca to develop specialized artificial intelligence…
MSD, Google Cloud Forge $1B AI Partnership
MSD, known as Merck & Co., Inc. in the United States, has entered into a major multi-year partnership with…
Drug Research
Latus Bio Raises $97 Million to Advance Gene Therapies
Latus Bio, Inc. has secured $97 million in Series A financing to accelerate the development of its gene therapy…
UK Streamlines Drug Approvals to Accelerate Patient Access
The Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care…
Novartis Targets Breast Cancer With Novel PI3Kα Inhibitor Deal
Novartis has announced a strategic agreement with Synnovation Therapeutics, LLC to acquire SNV4818, an…
FDA Proposes New Steps to Streamline Biosimilar Drug Development
The U.S. Food and Drug Administration has announced a new regulatory initiative aimed at accelerating the…
Insilico, CMS Partner on AI Drug Discovery Programs
Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical…
Manufacturing
Piramal, Ajinomoto Partner to Advance ADC Manufacturing Capabilities
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at…
UCB Selects Georgia for Major U.S. Biologics Manufacturing Hub
UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia,…
LGM Pharma Expands U.S. Manufacturing With $15M Investment
LGM Pharma has announced a $9 million expansion across its U.S. manufacturing network, marking the second phase of…
Terumo BCT, Taiwan Bio Partner on Treg Manufacturing
Terumo Blood and Cell Technologies (Terumo BCT) has entered into a strategic collaboration with Taiwan Bio…
CordenPharma Leases New Lab Facility at Boulder’s Flatiron Park
BioMed Realty has announced that CordenPharma Colorado has signed a long-term lease for a new laboratory facility…
Novo Nordisk Invests €432M to Expand Irish GLP-1 Manufacturing
Pharmaceutical giant Novo Nordisk has announced a €432 million investment to expand its manufacturing facility in…
AbbVie Invests $380M in North Chicago Manufacturing
AbbVie has unveiled plans to invest $380 million to construct two new active pharmaceutical ingredient (API)…
Johnson & Johnson Invests $1 Billion in Pennsylvania
Johnson & Johnson has announced plans to invest more than $1 billion in a next-generation cell therapy…
Diseases
Tenaya and Alnylam Partner to Discover New Genetic Targets for Heart Disease
Clinical-stage biotechnology company Tenaya Therapeutics has announced a new research collaboration with RNA…
AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies
AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic…
China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer
China’s National Medical Products Administration (NMPA) has approved ENHERTU® (trastuzumab deruxtecan) for the…
InterAx, Alveus Partner to Advance Next-Generation Obesity Therapy
InterAx Biotech Ltd and Alveus Therapeutics Inc. have entered into a strategic research collaboration and licensing…
Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet
Sandoz has signed a non-binding term sheet with Evotec SE to potentially acquire Just–Evotec Biologics EU SAS,…
AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana
Since announcing their partnership in April 2025, AstraZeneca and Revna Biosciences have made significant strides…
